FDA NDC Directory · JSON-LD · Markdown

SODIUM POLYSTYRENE SULFONATE

NDC 11534-166 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Generic namesodium polystyrene sulfonate
Labeler / ManufacturerSUNRISE PHARMACEUTICAL, INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA204071
Dosage form / routePOWDER, FOR SUSPENSION · ORAL RECTAL
Active ingredientsSODIUM POLYSTYRENE SULFONATE (4.1 meq/g)
Marketing started20170124
Package count3

External sources

Source: openFDA. Public-domain (CC0).